109 related articles for article (PubMed ID: 32416752)
1. The Influence of the Genetic and Immunologic Context in the Development of Colorectal Adenoma: A Case Series Report.
Garcia D; Spaans L; Miranda S; Gonçalves G; Reis J; Costa JL; Durães C; Carneiro F; Machado JC
Acta Med Port; 2020 May; 33(5):297-304. PubMed ID: 32416752
[TBL] [Abstract][Full Text] [Related]
2. The Adaptive Immune Landscape of the Colorectal Adenoma-Carcinoma Sequence.
Freitas JA; Gullo I; Garcia D; Miranda S; Spaans L; Pinho L; Reis J; Sousa F; Baptista M; Resende C; Leitão D; Durães C; Costa JL; Carneiro F; Machado JC
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575971
[TBL] [Abstract][Full Text] [Related]
3. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
[TBL] [Abstract][Full Text] [Related]
5. Matrilysin gene expression in sporadic and familial colorectal adenomas.
Takeuchi N; Ichikawa Y; Ishikawa T; Momiyama N; Hasegawa S; Nagashima Y; Miyazaki K; Koshikawa N; Mitsuhashi M; Shimada H
Mol Carcinog; 1997 Aug; 19(4):225-9. PubMed ID: 9290698
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients.
Wynter CV; Kambara T; Walsh MD; Leggett BA; Young J; Jass JR
Int J Cancer; 2006 Feb; 118(4):907-15. PubMed ID: 16152625
[TBL] [Abstract][Full Text] [Related]
7. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Chang K; Taggart MW; Reyes-Uribe L; Borras E; Riquelme E; Barnett RM; Leoni G; San Lucas FA; Catanese MT; Mori F; Diodoro MG; You YN; Hawk ET; Roszik J; Scheet P; Kopetz S; Nicosia A; Scarselli E; Lynch PM; McAllister F; Vilar E
JAMA Oncol; 2018 Aug; 4(8):1085-1092. PubMed ID: 29710228
[TBL] [Abstract][Full Text] [Related]
8. Congenital genetic instability in colorectal carcinomas.
Svendsen LB
Dan Med Bull; 1993 Nov; 40(5):546-56. PubMed ID: 8299399
[TBL] [Abstract][Full Text] [Related]
9. The Immune Landscapes of Polypoid and Nonpolypoid Precancerous Colorectal Lesions.
Maglietta A; Maglietta R; Staiano T; Bertoni R; Ancona N; Marra G; Resta L
PLoS One; 2016; 11(7):e0159373. PubMed ID: 27441558
[TBL] [Abstract][Full Text] [Related]
10. p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
Levi E; Stryker SJ; Rao MS
Am J Gastroenterol; 1996 Jan; 91(1):11-4. PubMed ID: 8561108
[TBL] [Abstract][Full Text] [Related]
11. Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway.
Estrella JS; Taggart MW; Rashid A; Abraham SC
Hum Pathol; 2014 Oct; 45(10):2051-8. PubMed ID: 25149552
[TBL] [Abstract][Full Text] [Related]
12. Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology.
Wallace K; El Nahas GJ; Bookhout C; Thaxton JE; Lewin DN; Nikolaishvili-Feinberg N; Cohen SM; Brazeal JG; Hill EG; Wu JD; Baron JA; Alekseyenko AV
Cancer Prev Res (Phila); 2021 Sep; 14(9):885-892. PubMed ID: 34341013
[TBL] [Abstract][Full Text] [Related]
13. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis.
Fearnhead NS; Wilding JL; Bodmer WF
Br Med Bull; 2002; 64():27-43. PubMed ID: 12421723
[TBL] [Abstract][Full Text] [Related]
14. A multi-stage model of adenoma development.
Pinsky PF
J Theor Biol; 2000 Nov; 207(2):129-43. PubMed ID: 11034825
[TBL] [Abstract][Full Text] [Related]
15. Immune microenvironmental shift along human colorectal adenoma-carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?
Cui G; Shi Y; Cui J; Tang F; Florholmen J
Scand J Gastroenterol; 2012 Apr; 47(4):367-77. PubMed ID: 22229663
[TBL] [Abstract][Full Text] [Related]
16. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
[TBL] [Abstract][Full Text] [Related]
17. Changes of immunocytic phenotypes and functions from human colorectal adenomatous stage to cancerous stage: Update.
Shi Y; Li Z; Zheng W; Liu X; Sun C; Laugsand JB; Liu Z; Cui G
Immunobiology; 2015 Oct; 220(10):1186-96. PubMed ID: 26153874
[TBL] [Abstract][Full Text] [Related]
18. [Application of serum protein markers to distinguish familial adenomatous polyposis (FAP) and sporadic colorectal adenomas].
Cai SR; Yu JK; Jiang WZ; Zhang SZ; Zheng S
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):192-5. PubMed ID: 19615258
[TBL] [Abstract][Full Text] [Related]
19. Clonality of dysplastic epithelium in colorectal adenomas from familial adenomatous polyposis patients.
Bjerknes M; Cheng H; Kim H; Schnitzler M; Gallinger S
Cancer Res; 1997 Feb; 57(3):355-61. PubMed ID: 9012454
[TBL] [Abstract][Full Text] [Related]
20. HLA antigens on colorectal adenoma and cancer cells.
Horie Y; Chiba M; Iizuka M; Igarashi K; Masamune O
Tohoku J Exp Med; 1990 Apr; 160(4):311-22. PubMed ID: 2382260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
